Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.75
-0.08-2.09%
Dern. MÀJ: Oct 23, 9:27 AM
Market sentiment signals for Aclaris Therapeutics (ACRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
16 analysts
Options Flow (P/C)
—
Avg Consensus PT
$10
+164.1%
Highest Price Target
$16
+332.4%
Lowest Price Target
$1
-73.0%
Short Interest
14.0%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Canaccord Genuity | Edward Nash— | +170.3% | $10 | Initiate | Buy |
| Jun 2, 2026 | LifeSci Capital | —— | +251.4% | $13 | Initiate | Outperform |
